Cas:81569-25-7 Methyl 2-amino-5-isopropylthiazole-4-carboxylate manufacturer & supplier

We serve Chemical Name:Methyl 2-amino-5-isopropylthiazole-4-carboxylate CAS:81569-25-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Methyl 2-amino-5-isopropylthiazole-4-carboxylate

Chemical Name:Methyl 2-amino-5-isopropylthiazole-4-carboxylate
CAS.NO:81569-25-7
Synonyms:methyl 2-amino-5-propan-2-yl-1,3-thiazole-4-carboxylate
Molecular Formula:C8H12N2O2S
Molecular Weight:200.25800
HS Code:2934100090

Physical and Chemical Properties:
Melting point:150-152ºC
Boiling point:337.1ºC at 760 mmHg
Density:1.233g/cm3
Index of Refraction:1.565
PSA:93.45000
Exact Mass:200.06200
LogP:2.21650

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like methyl 2-amino-5-propan-2-yl-1,3-thiazole-4-carboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,methyl 2-amino-5-propan-2-yl-1,3-thiazole-4-carboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,methyl 2-amino-5-propan-2-yl-1,3-thiazole-4-carboxylate Use and application,methyl 2-amino-5-propan-2-yl-1,3-thiazole-4-carboxylate technical grade,usp/ep/jp grade.


Related News: Immunocompromised people account for roughly 2.7% of U.S. adults including patients who’ve received an organ transplant, living with HIV or have received active or recent treatment for cancer, Oliver said. 4-[bis(2-methylpropyl)amino]butan-1-ol manufacturers Aduhelm was approved by the Food and Drug Administration on June 7. The drug, scientifically known as aducanumab, offers new hope to friends and families of patients living with the disease and is expected to generate billions of dollars in revenue for the company. 5,6,7-trichloroindoline-2,3-dione suppliers In the US, avalglucosidase alfa saw its PDUFA date pushed back by three months, from May 18 to Aug. 18, according to a Sanofi investor presentation in April. 4-Methyl-5-(1-methylethoxy)-9H-pyrido[3,4-b]indole-3-carboxylicacidethylesterhydrochloride vendor & factory.